Research Article: A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout
Abstract:
Background: Since NEK7 is critical for NLRP3 inflammasome activation, NEK7 inhibitors could be employed as therapeutic agents against gout, a representative disease caused by NLRP3 inflammasome.
No summary available.